IPM’s Application for Dapivirine Vaginal Ring for Reducing HIV Risk in Women Now Under Review by European Medicines Agency

In a July 13, 2017 press release, the International Partnership for Microbicides (IPM) announces that its application for the monthly dapivirine vaginal ring is under review by the European Medicines Agency (EMA). The release also outlines plans to submit applications to other regulatory authorities in pursuit of licensure.

Year: 
2017
Organization: 
International Partnership for Microbicides
Languages: 
English